Exon Splice Enhancer Mutation (GH-E32A) Causes Autosomal Dominant Growth Hormone Deficiency
Author(s) -
Vibor Petkovic,
Didier Lochmatter,
James Turton,
Peter Clayton,
Peter Trainer,
Mehul Dattani,
Andrée Eblé,
Iain C. A. F. Robinson,
Christa E. Flück,
Primus E. Mullis
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-0857
Subject(s) - exon , biology , gene isoform , ighd , rna splicing , microbiology and biotechnology , mutation , splice site mutation , intron , endocrinology , alternative splicing , splice , medicine , gene , genetics , growth hormone , rna , growth hormone deficiency , hormone
Alteration of exon splice enhancers (ESE) may cause autosomal dominant GH deficiency (IGHD II). Disruption analysis of a (GAA) (n) ESE motif within exon 3 by introducing single-base mutations has shown that single nucleotide mutations within ESE1 affect pre-mRNA splicing.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom